SUBSCRIBE
SUBSCRIBE
News   Drug Development

Roche (JOBS), Novartis Corporation (JOBS) Asthma Drug Effect Modest - FDA Staff

November 16, 2009 | 
1 min read
Bookmark and Share

Reuters -- An asthma drug from Roche and Novartis has "somewhat modest" benefits for kids aged 6 to 11, U.S. reviewers said in documents released on Monday.
Clinical research Postmarket research
Food and Drug Administration (FDA) Roche
MORE ON THIS TOPIC
The headquarters of Intellia Therapeutics, a brick building with two triangular shapes in its roof
Gene therapy
Patient Dies After Receiving Intellia’s CRISPR Gene Therapy Candidate
November 7, 2025
 · 
2 min read
 · 
Tristan Manalac
Eli Lilly's world headquarters in Indianapolis
Obesity
Lilly’s Amylin Agonist Headed to Phase III After Eliciting up to 20% Weight Loss
November 6, 2025
 · 
3 min read
 · 
Heather McKenzie
IN PARTNERSHIP WITH PII
Thoughtful Tech: How Removing Technological Burdens Can Improve Clinical Trial Compliance and Patient Experience
November 6, 2025
 · 
1 min read
 · 
BioSpace Insights
FDA
Webinar: FDA in 2025: Navigating an Uncertain Regulatory Future
November 5, 2025
 · 
1 min read
 · 
Jef Akst